OctreoScan: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
[[Image:Normal-octreoscan-004.jpg|right|300px]]
[[Image:Normal-octreoscan-004.jpg|right|300px]]
{{SI}}


==Indications for imaging==
{{EH}}
 
==Indications for OctreoScan imaging==


* Tumor evaluation  
* Tumor evaluation  

Revision as of 16:54, 26 February 2009

WikiDoc Resources for OctreoScan

Articles

Most recent articles on OctreoScan

Most cited articles on OctreoScan

Review articles on OctreoScan

Articles on OctreoScan in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on OctreoScan

Images of OctreoScan

Photos of OctreoScan

Podcasts & MP3s on OctreoScan

Videos on OctreoScan

Evidence Based Medicine

Cochrane Collaboration on OctreoScan

Bandolier on OctreoScan

TRIP on OctreoScan

Clinical Trials

Ongoing Trials on OctreoScan at Clinical Trials.gov

Trial results on OctreoScan

Clinical Trials on OctreoScan at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on OctreoScan

NICE Guidance on OctreoScan

NHS PRODIGY Guidance

FDA on OctreoScan

CDC on OctreoScan

Books

Books on OctreoScan

News

OctreoScan in the news

Be alerted to news on OctreoScan

News trends on OctreoScan

Commentary

Blogs on OctreoScan

Definitions

Definitions of OctreoScan

Patient Resources / Community

Patient resources on OctreoScan

Discussion groups on OctreoScan

Patient Handouts on OctreoScan

Directions to Hospitals Treating OctreoScan

Risk calculators and risk factors for OctreoScan

Healthcare Provider Resources

Symptoms of OctreoScan

Causes & Risk Factors for OctreoScan

Diagnostic studies for OctreoScan

Treatment of OctreoScan

Continuing Medical Education (CME)

CME Programs on OctreoScan

International

OctreoScan en Espanol

OctreoScan en Francais

Business

OctreoScan in the Marketplace

Patents on OctreoScan

Experimental / Informatics

List of terms related to OctreoScan

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Indications for OctreoScan imaging

  • Tumor evaluation

Patient preparation

  • Bowel preparation with laxative and enema
  • Discontinue octeotide therapy for 1 week prior the exam

Radiopharmaceutical

  • In-111 OctreoScan

Dose and route of administration

  • 6 mCi IV
    • 4 hours (abdomen, pelvis)
    • 24 hours (whole body)

Equipment

  • Camera: Large field of view SPECT gamma camera
  • Collimator: Medium-energy
  • Window: 20% window around 173 and 245 KeV

Procedure

  • 4 hours: Planar images of the abdomen and pelvis
  • 24 hours: Planar images of the whole body. SPECT of regions of clinical concern.

Images

Normal OctreoScan

References

  • Ziessman, Harvey A, O'Malley, Janis P, and Thrall, James M. Nuclear Medicine: The Requisites. 3rd ed. Philadelphia, Pennsylvania: Mosby, 2006. ISBN 0323029469